Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Contemporary Amperex Technology / Equity Capital Markets

Contemporary Amperex Technology (3750 HK)

<ul>
<li>Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.</li>
<li>On the IPO front, <a href="https://www.smartkarma.com/entities/shanghai-xizhi-technology-lightelligence" target="_blank" data-smartkarma-citation="entities:48061:1" rel="noopener">Shanghai Xizhi Technology (Lightelligence) (1879 HK)</a> recorded one of the highest demands yet.</li>
<li>On the placement front, <a href="https://www.smartkarma.com/entities/contemporary-amperex-technology-catl-co-limited" target="_blank" data-smartkarma-citation="entities:45179:1" rel="noopener">Contemporary Amperex Technology (CATL) (3750 HK)</a> finally got its H-share listing done.</li>
</ul>


Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
On the IPO front, Shanghai Xizhi Technology (Lightelligence) (1879 HK) recorded one of the highest demands yet.
On the placement front, Contemporary Amperex Technology (CATL) (3750 HK) finally got its H-share listing done.


Aequitas ECM Weekly (4 May 2026)- CATL, Innolight, Lightelligence, Unimicron, Cofoe, Lenskart, Seres

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

Contemporary Amperex Technology / Event-Driven

<ul>
<li>
<strong><a href="https://www.smartkarma.com/entities/contemporary-amperex-technology-co-limited" target="_blank" data-smartkarma-citation="entities:45179:1" rel="noopener">Contemporary Amperex Technology (3750 HK)</a></strong> (CATL H), a global leader in providing battery solutions, was listed on the 20th May at <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0516/2025051601205.pdf" target="_blank" rel="noopener">$263/share</a>. <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0512/2025051200005.pdf" target="_blank" rel="noopener">Here</a> is the prospectus.</li>
<li>Via the H-share listing, CATL raised ~US$5.2bn. Shares have since gained ~26% and trade at HK$330/share, as I type.</li>
<li>It is worth noting the HKEx issued a high concentration warning in CATL's H shares the day before shares were listed.</li>
</ul>



Contemporary Amperex Technology (3750 HK) (CATL H), a global leader in providing battery solutions, was listed on the 20th May at $263/share. Here is the prospectus.
Via the H-share listing, CATL raised ~US$5.2bn. Shares have since gained ~26% and trade at HK$330/share, as I type.
It is worth noting the HKEx issued a high concentration warning in CATL's H shares the day before shares were listed.


Pan-Asia Tactical Market Calls (Quant-Driven), MRM Research

Nico Rosti

Pan-Asia Tactical Market Calls (Quant-Driven)

MRM Research

Quantitative Research

Equity Derivatives

Contemporary Amperex Technology (CATL) / Equity Derivatives

Contemporary Amperex Technology (CATL) (300750 CH)

<ul>
<li>
<a href="https://www.smartkarma.com/entities/contemporary-amperex-technology-catl-co-limited" target="_blank" data-smartkarma-citation="entities:45179:1" rel="noopener">CATL (3750 HK)</a> stock dropped nearly 7% on Tuesday, April 28, after announcing a massive (62.4M) share placement at a discount. <a href="https://www.smartkarma.com/entities/contemporary-amperex-technolog" target="_blank" data-smartkarma-citation="entities:24404:1" rel="noopener">CATL (300750 CH)</a> fell only 1.66%.</li>
<li>Quantitative <strong>DAILY</strong> model analysis of <a href="https://www.smartkarma.com/entities/contemporary-amperex-technolog" target="_blank" data-smartkarma-citation="entities:24404:1" rel="noopener">CATL (300750 CH)</a> identifying short-term support targets and projected price action for the next trading sessions.</li>
<li>We expect a rebound on Wednesday/Thursday, support around 420 looks statistically quite solid, according to our model.</li>
</ul>



CATL (3750 HK) stock dropped nearly 7% on Tuesday, April 28, after announcing a massive (62.4M) share placement at a discount. CATL (300750 CH) fell only 1.66%.
Quantitative DAILY model analysis of CATL (300750 CH) identifying short-term support targets and projected price action for the next trading sessions.
We expect a rebound on Wednesday/Thursday, support around 420 looks statistically quite solid, according to our model.


CATL (300750 CH): Tactical Outlook After Discounted Share Placement Announcement

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

Contemporary Amperex Technology / Index Rebalance

<ul>
<li>We assess the HSI and HSCEI index impact of CATL's 62.4m primary share placement across four review cycles to May 2027.</li>
<li>HSI weight rises toward 0.8–0.9% at the Sep 2026 rebalance; HSCEI inclusion likely by Feb 2027 as post-placement shares dominate the MV12 window.</li>
<li>Two passive flow events totalling 5.36m shares for HSI and HSCEI will happen over two implementation cycles.</li>
</ul>


We assess the HSI and HSCEI index impact of CATL's 62.4m primary share placement across four review cycles to May 2027.
HSI weight rises toward 0.8–0.9% at the Sep 2026 rebalance; HSCEI inclusion likely by Feb 2027 as post-placement shares dominate the MV12 window.
Two passive flow events totalling 5.36m shares for HSI and HSCEI will happen over two implementation cycles.


CATL-H Placement: HSI and HSCEI Index Impact

<ul>
<li>
<a href="https://www.smartkarma.com/entities/contemporary-amperex-technology-catl-co-limited" target="_blank" data-smartkarma-citation="entities:45179:1" rel="noopener">Contemporary Amperex Technology (CATL) (3750 HK)</a> (CATL) is now looking to raise US$5bn via issuing new shares.</li>
<li>Two weeks ago we wrote about how CATL could look to raise US$5bn via a primary issuance, since then nearly US$4.5bn worth of secondary deals have taken place.</li>
<li>In this note, we run the deal through our ECM framework and talk about the deal dynamics.</li>
</ul>



Contemporary Amperex Technology (CATL) (3750 HK) (CATL) is now looking to raise US$5bn via issuing new shares.
Two weeks ago we wrote about how CATL could look to raise US$5bn via a primary issuance, since then nearly US$4.5bn worth of secondary deals have taken place.
In this note, we run the deal through our ECM framework and talk about the deal dynamics.


Aequitas: CATL H-Share Placement- Will Be Very Well Flagged US$5bn Deal but Last Deal Didn’t Do Well

China

Contemporary Amperex Technology Co., Limited. operates as a battery products manufacturing company. The Company produces and sells power battery materials, energy storage batteries energy storage battery cells, systems, and other products. Contemporary Amperex Technology also provides batteries recycling services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Contemporary Amperex Technology (CATL) (300750 CH)

Aequitas ECM Weekly (4 May 2026)- CATL, Innolight, Lightelligence, Unimicron, Cofoe, Lenskart, Seres

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

CATL (3750 HK)'s Concentration Warning

As well flagged, CATL entered into an agreement this week to place out 62.4mn new shares (1.36% of shares out, 40% of H-shares) at HK$628.20/share...

David Blennerhassett

CATL-H Placement: HSI and HSCEI Index Impact

CATL-H placement: we forecast HSI and HSCEI index impact from the 40% new free float shares across four review cycles, with HSCEI inclusion likely...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Aequitas ECM Weekly (4 May 2026)- CATL, Innolight, Lightelligence, Unimicron, Cofoe, Lenskart, Seres

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

CATL (3750 HK)'s Concentration Warning

As well flagged, CATL entered into an agreement this week to place out 62.4mn new shares (1.36% of shares out, 40% of H-shares) at HK$628.20/share...

David Blennerhassett

CATL (300750 CH): Tactical Outlook After Discounted Share Placement Announcement

​CATL (300750 CH) fell 1.66% after the share placement announcement on Apr 27. Our quantitative model flagged the stock as DEEPLY OVERSOLD and...

Nico Rosti

CATL-H Placement: HSI and HSCEI Index Impact

CATL-H placement: we forecast HSI and HSCEI index impact from the 40% new free float shares across four review cycles, with HSCEI inclusion likely...

Ke Yan, CFA, FRM

Aequitas: CATL H-Share Placement- Will Be Very Well Flagged US$5bn Deal but Last Deal Didn’t Do Well

Contemporary Amperex Technology (CATL) (3750 HK) (CATL) is now looking to raise US$5bn via issuing new shares. In this note, we talk about the deal...

Sumeet Singh

CATL (300750 CH) fell 1.66% after the share placement announcement on Apr 27. Our quantitative model flagged the stock as DEEPLY OVERSOLD and...